Temitayo Ayetoto-Oladehinde, Author at Businessday NG https://businessday.ng/author/temitayo-ayetoto/ Tue, 25 Apr 2023 21:26:08 +0000 en-US hourly 1 188198514 SA races ahead of Nigeria to fund post-COVID strategy https://businessday.ng/health/article/sa-races-ahead-of-nigeria-to-fund-post-covid-strategy/ https://businessday.ng/health/article/sa-races-ahead-of-nigeria-to-fund-post-covid-strategy/#respond Wed, 26 Apr 2023 01:30:16 +0000 https://businessday.ng/?p=724672 COVID-19

More than a year after Nigeria secured a spot on the first list of six African countries to receive the mRNA vaccine technology to build an independent vaccine production system, Africa’s largest economy has yet to unveil strategies to set the process in motion, particularly funding. The transfer of the technology, which birthed the unconventional […]

read more SA races ahead of Nigeria to fund post-COVID strategy

]]>
https://businessday.ng/health/article/sa-races-ahead-of-nigeria-to-fund-post-covid-strategy/feed/ 0 724672
WHO fears huge biological risk as Sudan fighting hits disease lab https://businessday.ng/world/article/who-fears-huge-biological-risk-as-sudan-fighting-hits-disease-lab/ https://businessday.ng/world/article/who-fears-huge-biological-risk-as-sudan-fighting-hits-disease-lab/#respond Tue, 25 Apr 2023 14:47:13 +0000 https://businessday.ng/?p=724613 Sudan

The World Health Organisation (WHO) has expressed fears that the capturing of an internationally-funded laboratory holding infectious disease samples by fighters in Sudan’s capital, Khartoum could pose a “huge biological risk”. Nima Saeed Abid, the WHO’s representative in Sudan said fighters had “kicked out all the technicians from the lab which is completely under the […]

read more WHO fears huge biological risk as Sudan fighting hits disease lab

]]>
https://businessday.ng/world/article/who-fears-huge-biological-risk-as-sudan-fighting-hits-disease-lab/feed/ 0 724613
Malaria overdiagnosis leaves deadlier diseases unchecked https://businessday.ng/health/article/malaria-overdiagnosis-leaves-deadlier-diseases-unchecked/ https://businessday.ng/health/article/malaria-overdiagnosis-leaves-deadlier-diseases-unchecked/#respond Thu, 20 Apr 2023 01:50:36 +0000 https://businessday.ng/?p=723449 malaria treatment

The overdiagnosis of malaria parasite by health providers is helping deadlier diseases such as pneumonia to evade medical scrutiny, raising the risk of childhood mortality in Nigeria. Over half of malaria treatments in Nigeria still occur without diagnosis despite widespread availability of malaria rapid diagnostic test (mRDT), an expert study published in the journal, Global […]

read more Malaria overdiagnosis leaves deadlier diseases unchecked

]]>
https://businessday.ng/health/article/malaria-overdiagnosis-leaves-deadlier-diseases-unchecked/feed/ 0 723449
Over half of malaria treatments occur without test – Study https://businessday.ng/health/article/over-half-of-malaria-treatments-occur-without-test-study/ https://businessday.ng/health/article/over-half-of-malaria-treatments-occur-without-test-study/#respond Wed, 19 Apr 2023 12:21:18 +0000 https://businessday.ng/?p=723362 malaria test

Over half of malaria treatments in Nigeria still occur without diagnosis despite widespread availability of malaria rapid diagnostic test (mRDT). More physicians trivialise test-based verification to assume that every patient presenting with fever or a history of fever should be prescribed malaria treatment, usually with artemisinin-based combination therapy (ACT), an expert study published in the […]

read more Over half of malaria treatments occur without test – Study

]]>
https://businessday.ng/health/article/over-half-of-malaria-treatments-occur-without-test-study/feed/ 0 723362
With new investment, R-jolad scales to meet mid-class demands https://businessday.ng/companies/article/with-new-investment-r-jolad-scales-to-meet-mid-class-demands/ https://businessday.ng/companies/article/with-new-investment-r-jolad-scales-to-meet-mid-class-demands/#respond Tue, 18 Apr 2023 10:26:37 +0000 https://businessday.ng/?p=723036 R-Jolad plus

R-Jolad, a Multi-Specialist hospital group in Nigeria providing quality and affordable healthcare, has recently unveiled the new R-Jolad Plus facility, a premium and affordable hospital chain designed to provide the middle-income class with a multi-specialized medical experience in Gbagada, Lagos. Prior to this, R-Jolad Hospital fondly known as the People’s Hospital has been operating as […]

read more With new investment, R-jolad scales to meet mid-class demands

]]>
https://businessday.ng/companies/article/with-new-investment-r-jolad-scales-to-meet-mid-class-demands/feed/ 0 723036